1.3200
+0.0100
+(0.76%)
As of 3:29:02 PM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Sebastien Ladet Ph.D. | Chief Executive Officer | 278.96k | -- | -- |
| Christophe de Vregille | Chief Financial Officer | -- | -- | -- |
| Ms. Celine Buard | Marketing Director | -- | -- | -- |
| Melanie Cantal | Human Resources Manager | -- | -- | -- |
| Mr. Nicolas Barry Delongchamps M.D. | Chief Medical Officer & Member of Scientific Advisory Board | -- | -- | -- |
| Prof. Francois Laborde M.D., Ph.D. | Chief Surgical Officer | -- | -- | -- |
| Mr. Olivier Pierron | Deputy Chief Executive Officer | -- | -- | 1969 |
| Mr. Benjamin Renault Ph.D. | Chief Development Officer | -- | -- | -- |
| Dr. Howard C. Herrmann M.D. | Chief Medical Officer | -- | -- | -- |
Affluent Medical SA
320, avenue Archimède
Les Pléiades III – Bâtiment B
Aix-en-Provence, 13100
France
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 66
Description
Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.
Corporate Governance
Affluent Medical SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available